Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Highlighting the clinical need for diagnosing Mycoplasma genitalium infection.

Ison CA, Fifer H, Gwynn S, Horner P, Muir P, Nicholls J, Radcliffe K, Ross J, Taylor-Robinson D, White J.

Int J STD AIDS. 2018 Jun;29(7):680-686. doi: 10.1177/0956462417753527. Epub 2018 Feb 10.

PMID:
29431025
2.

Microbiological techniques.

Ison CA.

Sex Transm Infect. 2017 Jun;93(4):302. doi: 10.1136/sextrans-2016-053012. Epub 2017 Mar 2. No abstract available.

PMID:
28254763
3.

Is there a role for topical antiseptics in the treatment of gonorrhoea?

Miari VF, Ison CA.

Sex Transm Infect. 2017 Mar;93(2):79-80. doi: 10.1136/sextrans-2016-053028. Epub 2016 Dec 30. No abstract available.

PMID:
28039432
4.

Trichomonas vaginalis infection is uncommon in the British general population: implications for clinical testing and public health screening.

Field N, Clifton S, Alexander S, Ison CA, Khanom R, Saunders P, Hughes G, Heath L, Beddows S, Mercer CH, Tanton C, Johnson AM, Sonnenberg P.

Sex Transm Infect. 2018 May;94(3):226-229. doi: 10.1136/sextrans-2016-052660. Epub 2016 Sep 29.

5.

Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.

Pond MJ, Hall CL, Miari VF, Cole M, Laing KG, Jagatia H, Harding-Esch E, Monahan IM, Planche T, Hinds J, Ison CA, Chisholm S, Butcher PD, Sadiq ST.

J Antimicrob Chemother. 2016 Apr;71(4):897-902. doi: 10.1093/jac/dkv432. Epub 2016 Jan 26.

6.

Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).

Sonnenberg P, Ison CA, Clifton S, Field N, Tanton C, Soldan K, Beddows S, Alexander S, Khanom R, Saunders P, Copas AJ, Wellings K, Mercer CH, Johnson AM.

Int J Epidemiol. 2015 Dec;44(6):1982-94. doi: 10.1093/ije/dyv194.

7.

Is chlamydia screening and testing in Britain reaching young adults at risk of infection? Findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).

Woodhall SC, Soldan K, Sonnenberg P, Mercer CH, Clifton S, Saunders P, da Silva F, Alexander S, Wellings K, Tanton C, Field N, Copas AJ, Ison CA, Johnson AM.

Sex Transm Infect. 2016 May;92(3):218-27. doi: 10.1136/sextrans-2015-052013. Epub 2015 Aug 19.

8.

Survey of the laboratory diagnosis of gonorrhoea and chlamydial infection in the UK.

Toby M, Saunders P, Ison CA.

Sex Transm Infect. 2015 Jun;91(4):299. doi: 10.1136/sextrans-2014-051749. No abstract available.

PMID:
25990783
9.

High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey.

Tanton C, Soldan K, Beddows S, Mercer CH, Waller J, Field N, Clifton S, Copas AJ, Panwar K, Manyenga P, da Silva F, Wellings K, Ison CA, Johnson AM, Sonnenberg P.

Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):842-53. doi: 10.1158/1055-9965.EPI-14-1333. Epub 2015 Mar 3.

10.

Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe.

Cole MJ, Spiteri G, Town K, Unemo M, Hoffmann S, Chisholm SA, Amato-Gauci AJ, van de Laar M, Ison CA; Euro-GASP Network.

Sex Transm Dis. 2014 Dec;41(12):723-9. doi: 10.1097/OLQ.0000000000000185.

PMID:
25581808
11.

Confirmatory assays are essential when using molecular testing for Neisseria gonorrhoeae in low-prevalence settings: insights from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).

Field N, Clifton S, Alexander S, Ison CA, Hughes G, Beddows S, Tanton C, Soldan K, Coelho da Silva F, Mercer CH, Wellings K, Johnson AM, Sonnenberg P.

Sex Transm Infect. 2015 Aug;91(5):338-41. doi: 10.1136/sextrans-2014-051850. Epub 2014 Dec 15.

12.

Can previous first-line therapies for Neisseria gonorrhoeae be targeted to specific patient subgroups to treat gonorrhea?

Town K, Lowndes CM, Hughes G, Obi C, Chisholm S, Ison CA; GRASP collaborative group.

Sex Transm Dis. 2015 Jan;42(1):37-42. doi: 10.1097/OLQ.0000000000000223.

PMID:
25504299
13.

Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.

Cole MJ, Spiteri G, Chisholm SA, Hoffmann S, Ison CA, Unemo M, Van de Laar M.

Euro Surveill. 2014 Nov 13;19(45):20955.

14.

Frequency and correlates of culture-positive infection with Neisseria gonorrhoeae in England: a review of sentinel surveillance data.

Mohammed H, Ison CA, Obi C, Chisholm S, Cole M, Quaye N, Hughes G; GRASP Collaborative Group.

Sex Transm Infect. 2015 Jun;91(4):287-93. doi: 10.1136/sextrans-2014-051756. Epub 2014 Oct 28. Review.

PMID:
25352692
15.

Screening for gonorrhoea using samples collected through the English national chlamydia screening programme and risk of false positives: a national survey of local authorities.

Field N, Kennedy I, Folkard K, Duffell S, Town K, Ison CA, Hughes G.

BMJ Open. 2014 Oct 16;4(10):e006067. doi: 10.1136/bmjopen-2014-006067.

16.

An evaluation of Neisseria gonorrhoeae antimicrobial susceptibility testing in the UK.

Jain A, Cole MJ, Planche T, Ison CA.

J Clin Pathol. 2014 Nov;67(11):1013-6. doi: 10.1136/jclinpath-2014-202392. Epub 2014 Jul 30.

PMID:
25078330
17.

Nucleic acid amplification tests for the diagnosis of Neisseria gonorrhoeae in low-prevalence settings: a review of the evidence.

Fifer H, Ison CA.

Sex Transm Infect. 2014 Dec;90(8):577-9. doi: 10.1136/sextrans-2014-051588. Epub 2014 Jul 10. Review.

PMID:
25013081
18.

Decreased susceptibility to cephalosporins among gonococci? Authors' reply.

Ison CA, Town K, Obi C, Chisholm S, Hughes G, Livermore DM, Lowndes CM.

Lancet Infect Dis. 2014 Mar;14(3):186-7. doi: 10.1016/S1473-3099(14)70023-4. No abstract available.

PMID:
24571973
19.

Evaluation of the activity of ertapenem against gonococcal isolates exhibiting a range of susceptibilities to cefixime.

Quaye N, Cole MJ, Ison CA.

J Antimicrob Chemother. 2014 Jun;69(6):1568-71. doi: 10.1093/jac/dkt537. Epub 2014 Feb 2.

PMID:
24492260
20.

Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal).

Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C, Mercer CH, da Silva FC, Alexander S, Copas AJ, Phelps A, Erens B, Prah P, Macdowall W, Wellings K, Ison CA, Johnson AM.

Lancet. 2013 Nov 30;382(9907):1795-806. doi: 10.1016/S0140-6736(13)61947-9. Epub 2013 Nov 26.

21.

Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union.

Unemo M, Ison CA, Cole M, Spiteri G, van de Laar M, Khotenashvili L.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv42-6. doi: 10.1136/sextrans-2012-050909. Review.

PMID:
24243879
22.

Gonococcal antimicrobial resistance: challenges for public health control.

Ndowa FJ, Ison CA, Cole MJ, Lusti-Narasimhan M.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv3-4. doi: 10.1136/sextrans-2013-051395. No abstract available.

PMID:
24243877
23.

Gonococcal antimicrobial resistance: the implications for public health control.

Ndowa FJ, Ison CA, Lusti-Narasimhan M.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv1-2. doi: 10.1136/sextrans-2013-051394. No abstract available.

PMID:
24243872
24.

Reaudit of laboratory diagnostic methods for syphilis 2011.

de Nobrega R, Manuel RJ, Amin AK, Shemko M, Paul J, Ison CA.

Sex Transm Infect. 2014 Feb;90(1):63. doi: 10.1136/sextrans-2013-051245. Epub 2013 Nov 11. No abstract available.

PMID:
24218646
25.

Current and future treatment options for gonorrhoea.

Ison CA, Deal C, Unemo M.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv52-6. doi: 10.1136/sextrans-2012-050913. Epub 2013 Oct 8. Review.

PMID:
24106339
26.

Presentation of clinically suspected persistent chlamydial infection: a case series.

Pitt RA, Alexander S, Horner PJ, Ison CA.

Int J STD AIDS. 2013 Jun;24(6):469-75. doi: 10.1177/0956462412472815. Epub 2013 Jul 4.

PMID:
23970750
27.

Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.

Ison CA, Town K, Obi C, Chisholm S, Hughes G, Livermore DM, Lowndes CM; GRASP collaborative group.

Lancet Infect Dis. 2013 Sep;13(9):762-8. doi: 10.1016/S1473-3099(13)70143-9. Epub 2013 Jun 11.

PMID:
23764300
28.

Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture.

Seth-Smith HM, Harris SR, Skilton RJ, Radebe FM, Golparian D, Shipitsyna E, Duy PT, Scott P, Cutcliffe LT, O'Neill C, Parmar S, Pitt R, Baker S, Ison CA, Marsh P, Jalal H, Lewis DA, Unemo M, Clarke IN, Parkhill J, Thomson NR.

Genome Res. 2013 May;23(5):855-66. doi: 10.1101/gr.150037.112. Epub 2013 Mar 22.

29.

Chlamydia point-of-care testing: where are we now?

Jain A, Ison CA.

Sex Transm Infect. 2013 Mar;89(2):88-9. doi: 10.1136/sextrans-2012-050834. No abstract available.

PMID:
23423334
30.

Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone.

Chisholm SA, Unemo M, Quaye N, Johansson E, Cole MJ, Ison CA, Van de Laar MJ.

Euro Surveill. 2013 Jan 17;18(3). pii: 20358.

31.

Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea: false negative gonococcal porA mutants are spreading internationally.

Ison CA, Golparian D, Saunders P, Chisholm S, Unemo M.

Sex Transm Infect. 2013 May;89(3):197-201. doi: 10.1136/sextrans-2012-050829. Epub 2012 Dec 13.

PMID:
23241969
32.

Molecular epidemiology of gonorrhoea in Wales (UK).

Cole MJ, Thomas DR, Chisholm SA, Abdullah AN, Birley H, Hosein I, Kubiak E, White D, Martin I, Ison CA.

Sex Transm Infect. 2013 May;89(3):267-72. doi: 10.1136/sextrans-2012-050663. Epub 2012 Dec 5.

PMID:
23220784
33.

Combination therapy for gonorrhoea: in vitro synergy testing.

Pereira R, Cole MJ, Ison CA.

J Antimicrob Chemother. 2013 Mar;68(3):640-3. doi: 10.1093/jac/dks449. Epub 2012 Nov 14.

PMID:
23152483
34.

Rapid increase in gonorrhoea and syphilis diagnoses in England in 2011.

Savage EJ, Marsh K, Duffell S, Ison CA, Zaman A, Hughes G.

Euro Surveill. 2012 Jul 19;17(29). pii: 20224.

35.

Chlamydia and gonorrhoea contamination of clinic surfaces.

Lewis N, Dube G, Carter C, Pitt R, Alexander S, Ison CA, Harding J, Brown L, Fryer J, Hodson J, Ross J.

Sex Transm Infect. 2012 Oct;88(6):418-21. Epub 2012 Apr 25.

PMID:
22535909
36.

Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment.

Ison CA.

Curr Opin Infect Dis. 2012 Feb;25(1):73-8. doi: 10.1097/QCO.0b013e32834e9a6a. Review.

PMID:
22143116
37.

The European gonococcal antimicrobial surveillance programme, 2009.

Cole MJ, Unemo M, Hoffmann S, Chisholm SA, Ison CA, van de Laar MJ.

Euro Surveill. 2011 Oct 20;16(42). pii: 19995.

38.

Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management.

Ison CA, Alexander S.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):867-76. doi: 10.1586/eri.11.103. Review.

PMID:
21973299
39.

Estimating the prevalence of gonococcal resistance to antimicrobials in England and Wales.

Hughes G, Nichols T, Ison CA.

Sex Transm Infect. 2011 Oct;87(6):526-31. doi: 10.1136/sextrans-2011-050071.

PMID:
21917698
40.

Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.

Chisholm SA, Alexander S, Desouza-Thomas L, Maclure-Webster E, Anderson J, Nichols T, Lowndes CM, Ison CA; GRASP Collaborative Group.

J Antimicrob Chemother. 2011 Nov;66(11):2509-12. doi: 10.1093/jac/dkr332. Epub 2011 Aug 16.

PMID:
21846672
41.

Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.

Ison CA, Hussey J, Sankar KN, Evans J, Alexander S.

Euro Surveill. 2011 Apr 7;16(14). pii: 19833.

42.

An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe.

Chisholm SA, Quaye N, Cole MJ, Fredlund H, Hoffmann S, Jensen JS, van de Laar MJ, Unemo M, Ison CA.

J Antimicrob Chemother. 2011 Mar;66(3):592-5. doi: 10.1093/jac/dkq476. Epub 2010 Dec 14.

PMID:
21172790
43.

Positive predictive value of the Becton Dickinson VIPER system and the ProbeTec GC Q x assay, in extracted mode, for detection of Neisseria gonorrhoeae.

Pope CF, Hay P, Alexander S, Capaldi K, Dave J, Sadiq ST, Ison CA, Planche T.

Sex Transm Infect. 2010 Nov;86(6):465-9. doi: 10.1136/sti.2010.044065.

PMID:
20940160
44.

European surveillance of antimicrobial resistance in Neisseria gonorrhoeae.

Cole MJ, Chisholm SA, Hoffmann S, Stary A, Lowndes CM, Ison CA; European Surveillance of Sexually Transmitted Infections Network.

Sex Transm Infect. 2010 Nov;86(6):427-32. doi: 10.1136/sti.2010.044164.

PMID:
20940154
45.

Gonorrhoea themed issue.

Ison CA, Hughes G.

Sex Transm Infect. 2010 Nov;86(6):409-11. doi: 10.1136/sti.2010.046821. No abstract available.

PMID:
20940151
46.

Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?

Chisholm SA, Mouton JW, Lewis DA, Nichols T, Ison CA, Livermore DM.

J Antimicrob Chemother. 2010 Oct;65(10):2141-8. doi: 10.1093/jac/dkq289. Epub 2010 Aug 6.

PMID:
20693173
47.

High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes.

Chisholm SA, Dave J, Ison CA.

Antimicrob Agents Chemother. 2010 Sep;54(9):3812-6. doi: 10.1128/AAC.00309-10. Epub 2010 Jun 28.

48.

Molecular epidemiology of syphilis in Scotland.

Cole MJ, Chisholm SA, Palmer HM, Wallace LA, Ison CA.

Sex Transm Infect. 2009 Oct;85(6):447-51. doi: 10.1136/sti.2009.036301. Epub 2009 Jun 3.

PMID:
19497918
49.

Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales.

Chisholm SA, Neal TJ, Alawattegama AB, Birley HD, Howe RA, Ison CA.

J Antimicrob Chemother. 2009 Aug;64(2):353-8. doi: 10.1093/jac/dkp188. Epub 2009 May 25.

PMID:
19468025
50.

Epidemiology and clinical presentation of gonorrhoea in England and Wales: findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme 2001-2006.

Delpech V, Martin IM, Hughes G, Nichols T, James L, Ison CA; Gonococcal Resistance to Antimicrobials Surveillance Programme Steering Group.

Sex Transm Infect. 2009 Sep;85(5):317-21. doi: 10.1136/sti.2008.034843. Epub 2009 Apr 20.

PMID:
19383598

Supplemental Content

Support Center